98%
921
2 minutes
20
Objective: To compare self-publication rates by editors-in-chief (EICs) of psychiatry vs. medicine journals before, during, and after their editorships.
Methods: Frequency of self-publication by 25 psychiatry EICs and 22 medicine EICs across seven journals in each specialty was determined for 5 years before, the years during, and 5 years after their tenures. PubMed was used to identify original research and review articles subject to peer review. Two-way ANOVA with repeated measures was used to assess differences in articles published per year by specialty and time period.
Results: Mean self-publication rates before, during, and after editorship were 0.64, 1.46, and 0.66 articles/year for psychiatry EICs and 0.25, 0.31, and 0.13 articles/year for medicine EICs. ANOVA revealed significant main effects of journal type (psychiatry vs. medicine) ( = 0.003) and time period (before, during, after) ( = 0.003), and a significant interaction ( = 0.024).
Conclusion: Psychiatry EICs self-published discretionary articles significantly more frequently (4.7 times overall) than did their medicine counterparts. These findings do not necessarily imply abuse, but they highlight the need to further enhance editorial safeguards, increase transparency, and continue surveillance of adherence to publication guidelines, in order to further mitigate potential conflicts of interest in academic publishing.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/08989621.2025.2551166 | DOI Listing |
JAMA Neurol
September 2025
Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Importance: Exposure to fine particulate matter air pollution (PM2.5) may increase risk for dementia. It is unknown whether this association is mediated by dementia-related neuropathologic change found at autopsy.
View Article and Find Full Text PDFJAMA Intern Med
September 2025
Bayer CC AG, Basel, Switzerland.
Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.
Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.
Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).
JAMA Pediatr
September 2025
Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Importance: For the first time in nearly 2 decades, the US infant mortality rate has increased, coinciding with a rise in overdose-related deaths as a leading cause of pregnancy-associated mortality in some states. Prematurity and low birth weight-often linked to opioid use in pregnancy-are major contributors.
Objective: To assess the health and economic impact of perinatal opioid use disorder (OUD) treatment on maternal and postpartum health, infant health in the first year of life, and infant long-term health.
J Dev Behav Pediatr
September 2025
Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston University, Boston, MA.
John is a 12-year-old African-American boy with a Specific Learning Disorder in Reading and Generalized Anxiety Disorder who you are seeing in follow-up at your clinic. Last fall, when John was having an escalation of his anxiety symptoms at school, he enacted the behavior intervention plan (BIP) that had been previously established by his educational team of informing his teacher that he needed to leave the classroom. He then paced the hallway outside of his classroom as a method of coping with the anxiety that he was experiencing.
View Article and Find Full Text PDFBrain
September 2025
Neurology Department, Civil Hospital of Guadalajara, 44280 Guadalajara, Jalisco, Mexico.